IGS technology (Innovir)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameIGS technology (Innovir)
Drug Alias Namedelta ribozyme technology (Innovir)hepatitis delta IGS (Innogen)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Ribozyme
Mechanisms of ActionVirus replication inhibitors
TargetsUpdating
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInnovir Laboratories Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInnovir Laboratories Inc
Active IndicationsN/A
Inactive IndicationsHepatitis B

Other Information

ATC CodeN/A
Related LinksN/A